Cargando…

Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1

The functions of dual-specificity phosphatase 9 (DUSP9) in hepatic steatosis and metabolic disturbance during nonalcoholic fatty liver disease were discussed in our prior study. However, its roles in the pathophysiology of pressure overload-induced cardiac hypertrophy remain to be illustrated. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Lang, Ren, Lingyun, Guo, Xin, Zhao, Jing, Zhang, Hao, Chen, Shanshan, Le, Sheng, Liu, Hao, Ye, Ping, Chen, Manhua, Xia, Jiahong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241718/ https://www.ncbi.nlm.nih.gov/pubmed/34239349 http://dx.doi.org/10.7150/ijbs.57130

Ejemplares similares

Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
por: Zhao, Jing, et al.
Publicado: (2021)

Dual‐Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression
por: Ye, Ping, et al.
Publicado: (2018)

Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 Suppression
por: Ye, Ping, et al.
Publicado: (2019)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
por: Xiang, Mei, et al.
Publicado: (2018)

Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway
por: Zhang, Bin-Bin, et al.
Publicado: (2021)

CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway
por: Li, Yue, et al.
Publicado: (2023)

Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway
por: Xiao, Lili, et al.
Publicado: (2017)

APJ ACTS AS A DUAL RECEPTOR IN CARDIAC HYPERTROPHY
por: Scimia, Maria Cecilia, et al.
Publicado: (2012)

A Disintegrin and Metalloprotease‐22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway
por: Ren, Lingyun, et al.
Publicado: (2018)

Renal replacement therapy after cardiac surgery: do not ask “When”, ask “Why”
por: Gaudry, Stéphane, et al.
Publicado: (2017)

Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis
por: Pan, Liming, et al.
Publicado: (2017)

Dual-Specificity Phosphatases in Immunity and Infection: An Update
por: Lang, Roland, et al.
Publicado: (2019)

Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy
por: Chang, Tzu-Hao, et al.
Publicado: (2016)

Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy
por: Eleftheriadou, Olga, et al.
Publicado: (2017)

Choline Protects Against Cardiac Hypertrophy Induced by Increased After-load
por: Zhao, Yilei, et al.
Publicado: (2013)

The art of asking questions /
por: Payne, Stanley Le Baron, 1911-
Publicado: (1980)

microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9
por: He, Zhonghan, et al.
Publicado: (2020)

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury
por: Yang, Xiaoyan, et al.
Publicado: (2023)

p47(phox)-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis
por: Liu, Fangfei, et al.
Publicado: (2021)

Dual Specificity Phosphatases: From Molecular Mechanisms to Biological Function
por: Pulido, Rafael, et al.
Publicado: (2019)

Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
por: Lu, Peilei, et al.
Publicado: (2022)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

ASK “to be, or not to be?”
por: Okazaki, Tomohiko
Publicado: (2015)

Asked for It
Publicado: (1915)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

Slowing Heart Rate Protects Against Pathological Cardiac Hypertrophy
por: Sebastian, Sonia, et al.
Publicado: (2022)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy
por: Xu, Man, et al.
Publicado: (2019)

MiRNAs as Biomarkers of Myocardial Infarction: A Meta-Analysis
por: Cheng, Chao, et al.
Publicado: (2014)

Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2020)

Actin-Binding Proteins in Cardiac Hypertrophy
por: Pan, Congbin, et al.
Publicado: (2022)

Targeting miR-30d reverses pathological cardiac hypertrophy
por: Li, Jin, et al.
Publicado: (2022)

Lipid phosphatase SHIP‐1 regulates chondrocyte hypertrophy and skeletal development
por: So, Eui‐Young, et al.
Publicado: (2019)

Angiotensin‐Converting Enzyme 3 (ACE3) Protects Against Pressure Overload‐Induced Cardiac Hypertrophy
por: Yu, Chang‐Jiang, et al.
Publicado: (2016)

Dual‐Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma
por: Chen, Kui, et al.
Publicado: (2021)

Expression of Dual-Specificity Phosphatase 9 in Placenta and Its Relationship with Gestational Diabetes Mellitus
por: Wei, Qiang, et al.
Publicado: (2019)

Circular RNAs in the regulation of cardiac hypertrophy
por: Wu, Siyi, et al.
Publicado: (2021)

Bioinformatics Analysis Reveals MicroRNAs Regulating Biological Pathways in Exercise-Induced Cardiac Physiological Hypertrophy
por: Xu, Jiahong, et al.
Publicado: (2017)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation
por: Cui, Jikai, et al.
Publicado: (2020)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation: Erratum
por: Cui, Jikai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v1tp5gsrjjfnm2pvei5fua6nus